ARTESUNATE AMIVAS 110 mg, powder and solvent for solution for injection 2 bottles of 12 ml
Active ingredients: Artesunate
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Powder and solvent for solution for injection2 bottles of 12 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ARTESUNATE AMIVAS 110 mg, poudre et solvant pour solution injectable
- Pharmaceutical form
- poudre et solvant pour solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 2 flacons en verre de 110 mg - 2 flacons en verre de 12 mL
- Marketing authorisation holder
- AMIVAS IRELAND (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 12 Jan 2026
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
66161933CIP75509829CIP133400955098294Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ARTÉSUNATEpoudre | 110 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.